Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 1998BloodOpen Access

Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease.

View Full Paper
Ask AI
Bookmark
Share

Authors

PGPaolo G. GobbiUniversity of PaviaCPCarla PierescaUniversity of PaviaMGMaria L. GhirardelliValmet Automotive (Finland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gobbi et al. (1998) studied this question.

synapsesocial.com/papers/6a86b53bb688e10ffe82a690https://doi.org/10.1182/blood.v91.8.2704.2704_2704_2712
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.1989 · 1,640 citations
  2. 2Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group study1983 · 43 citations
  3. 3Twenty years of MOPP therapy for Hodgkin's disease.1986 · 439 citations
  4. 4Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.1996 · 171 citations
  5. 5A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease1980 · 44 citations